Table 2.
Providers’ PrEP training content recommendations and format preferences relative to current PrEP implementation cascade stage
| Providers’ PrEP training needs | PrEP implementation cascade | |||
|---|---|---|---|---|
| Awareness of PrEP (n = 10) | Willing to prescribe PrEP (n = 18) | Discuss PrEP with patients (n = 44) | Actual prescription of PrEP (n = 287) | |
| n (%) | n (%) | n (%) | n (%) | |
| Training content recommendations | ||||
| HIV background | 2 (20.00) | 2 (11.11) | 12 (27.27) | 130 (45.30) |
| Efficacy of PrEP | 7 (70.00) | 11 (61.11) | 34 (77.27) | 245 (85.37) |
| Risks/side effects of PrEP | 9 (90.00) | 14 (77.78) | 35 (79.55) | 239 (83.28) |
| Clinical trial evidence for PrEP | 9 (90.00) | 11 (61.11) | 32 (72.73) | 223 (77.70) |
| Biological mechanisms of PrEP | 4 (40.00) | 3 (16.67) | 12 (27.27) | 127 (44.25) |
| Clinical protocol for initiating and monitoring patients on PrEP | 9 (90.00) | 15 (83.33) | 39 (88.64) | 257 (89.55) |
| How to take sexual history | 4 (40.00) | 5 (27.78) | 14 (31.82) | 190 (66.20) |
| How to talk about sex with a patient who is a sexual minority | 4 (40.00) | 5 (27.78) | 17 (38.64) | 173 (60.28) |
| PrEP adherence and drug resistance | 7 (70.00) | 10 (55.56) | 27 (61.36) | 183 (63.76) |
| Clinical guidelines for determining patient eligibility for PrEP | 8 (80.00) | 15 (83.33) | 36 (81.82) | 243 (84.67) |
| Other content recommendationsa | 0 (0.00) | 0 (0.00) | 0 (0.00) | 9 (3.14) |
| Training format preferences | ||||
| Informal lecture with PowerPoint slides | 7 (70.00) | 12 (66.67) | 20 (45.45) | 178 (62.02) |
| Case presentation of actual PrEP patient | 6 (60.00) | 8 (44.44) | 32 (72.73) | 216 (75.26) |
| Full group discussion of hypothetical patient case | 3 (30.00) | 4 (22.22) | 12 (27.27) | 116 (40.42) |
| Small group breakout sessions to discuss hypothetical patient case | 2 (20.00) | 2 (11.11) | 12 (27.27) | 76 (26.48) |
| Multiple trainers role playing how to talk to patients about PrEP | 6 (60.00) | 6 (33.33) | 25 (56.82) | 169 (58.89) |
| Audience members role playing how to talk to patients about PrEP | 2 (20.00) | 7 (38.89) | 17 (38.64) | 124 (43.21) |
| Question and Answer sessions with trainers using anonymous handheld devices | 3 (30.00) | 0.00 (0.00) | 12 (27.27) | 113 (39.37) |
| Open Question and Answer sessions with trainersa | 0.00 (0) | 0.00 (0) | 0.00 (0) | 2 (0.70) |
| Other format preferencesa | 3 (30.00) | 4 (22.22) | 19 (43.18) | 136 (47.39) |
aExcluded from analyses